Impact of comorbidities on survival in melanoma patients
Authors:
- Alessandra BujaABAlessandra Buja
- Fortunato CassaliaFortunato Cassalia
- Massimo RuggeMRMassimo Rugge
- Chiara TrevisiolCTChiara Trevisiol
- Manuel ZorziMZManuel Zorzi
- Paolo Del FiorePFPaolo Del Fiore
- Ilaria PantaleoIPIlaria Pantaleo
- Carlo Riccardo RossiCRCarlo Riccardo Rossi
- Pierfranco ContePCPierfranco Conte
- Anna Belloni FortinaAnna Belloni Fortina
- Simone MocellinSimone Mocellin
Open Access
- 25 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
The increasing incidence of cutaneous melanoma (CM) is a significant public health issue. However, few studies have focused on how comorbidity patterns mayKeywords
Funding Information
- Fondazione Periplo
- Ministero della Salute
This publication has 26 references indexed in Scilit:
- Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021Journal of the American Academy of Dermatology, 2024
- Comorbidities and perceived health status in persons with history of cancer in the USASupportive Care in Cancer, 2022
- Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitorsJournal of the American Academy of Dermatology, 2022
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040JAMA Dermatology, 2022
- Skin cancer: Primary, secondary, and tertiary prevention. Part IJournal of the American Academy of Dermatology, 2022
- Skin cancer: Primary, secondary, and tertiary prevention. Part II.Journal of the American Academy of Dermatology, 2022
- Melanoma in the very elderly, management in patients 85 years of age and overJournal of Geriatric Oncology, 2018
- Localized melanoma in older patients, the impact of increasing age and comorbid medical conditionsEuropean Journal of Surgical Oncology, 2016
- The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort studyBritish Journal of Cancer, 2013
- Latent Class and Latent Transition Analysis2009